Related Experiment Video
Updated: Jun 5, 2026
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks
1Section of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, USA. heather.carleton@yale.edu
The Yale Journal of Biology and Medicine
|December 18, 2010
Summary
Scientists are reprogramming bacteria to create advanced vaccines. This innovative approach protects against various diseases, including bacterial, viral, parasitic, and cancer, offering a new reality in disease prevention.
Area of Science:
- Microbiology and Immunology
- Vaccine Development
Background:
- Increasing knowledge of bacterial biology enables novel therapeutic applications.
- Traditional infection-based immunity is insufficient against diverse modern pathogens.
Purpose of the Study:
- To explore the reprogramming of bacteria as a novel vaccine strategy.
- To develop protective measures against a wide range of diseases using engineered bacteria.
Main Methods:
- Bacterial manipulation and genetic engineering techniques.
- In vivo and in vitro studies to assess protective efficacy.
Main Results:
- Demonstrated feasibility of using engineered bacteria for protection.
- Potential to confer immunity against bacterial, viral, and parasitic infections.
Conclusions:
- Reprogramming bacteria represents a paradigm shift in vaccine technology.
- Engineered bacteria offer a promising platform for combating diverse diseases, including cancer.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:33Bacterial Transformation
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
01:25Colonisation of Pathogens
Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
00:43Lysogenic Cycle of Bacteriophages
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...